|
Ablación por radiofrecuencia de la inervación simpática de arterias renales para hipertensión arterial refractaria [Actualization: radiofrequency sympathetic denervation of the renal arteries for refractory arterial hypertension] |
Pichon Riviere A, Augustovski F, Garcia Marti S, Alcaraz A, Glujovsky D, Lopez A, Rey-Ares L, Bardach A, Ciapponi A, Dehese J |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pichon Riviere A, Augustovski F, Garcia Marti S, Alcaraz A, Glujovsky D, Lopez A, Rey-Ares L, Bardach A, Ciapponi A, Dehese J. Ablación por radiofrecuencia de la inervación simpática de arterias renales para hipertensión arterial refractaria. [Actualization: radiofrequency sympathetic denervation of the renal arteries for refractory arterial hypertension] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rápida N° 307. 2013 Authors' objectives To assess the available evidence on the efficacy, safety and coverage related aspect regarding RSDRA use for refractory arterial hypertension. Authors' conclusions The evidence found was of moderate methodological quality. The use of RSDRA associated to the underlying medical treatment proved to be useful in reducing BP in RAH patients at short and middle term (up to 24 months). The procedure could be taken into account only in those RAH patients under treatment at the maximum tolerated doses and adequate adherence, who have failed with all previous measures and if carried out by highly-qualified professionals. Potential subgroups that might benefit could be patients with RAH and kidney failure, due to increase in their sympathetic activity. Long-term studies are required to further assess its indications as well as its morbidity and mortality. Indexing Status Subject indexing assigned by CRD MeSH Humans; Hypertension; Renal Artery; Sympathectomy; Sympathetic Nervous System Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32014000256 Date abstract record published 28/01/2014 |
|
|
|